However, adding GIP agonism significantly enhances results, suggesting GIP contributes meaningfully to overall weight loss through metabolic effects beyond pure appetite control
3,4 The decision was based on results from the landmark LEADER trial demonstrating that liraglutides significant reduction in the risk of a three-component endpoint consisting of cardiovascular death, non-fatal heart attack, or non-fatal stroke by 13% versus placebo (P = .01) with an absolute risk reduction (ARR) of 1.9%
(PubMed) Campone M, Berton-Rigaud D, Joly-Lobbedez F, et al
For someone specifically targeting skin quality and hair density, GHK-Cu has the strongest body of human clinical evidence among comparable peptides
Estrogen binding to estrogen receptor- (ER-) in osteoblasts induces the expression of Fas ligand (FasL), which activates the Fas/FasL extrinsic apoptotic pathway in osteoclasts, thereby limiting osteoclast lifespan